申请人:Array BioPharma, Inc.
公开号:US20170112849A1
公开(公告)日:2017-04-27
Methods for treating a disease or disorder selected from pain, cancer, inflammation, neurodegenerative disease,
Typanosoma cruzi
infection and osteolytic disease in a mammal, which comprise administering to said mammal a therapeutically effective amount of a compound of Formula I
in which R
1
, R
2
, R
3
, R
4
, X, Y and n have the meanings given in the specification.